Le plan pour financer l'accès territorial de soins (11 avril 2018) ,
, Consulté le 02 octobre, 2018.
De nouveaux schémas pour mieux comprendre les maladies de la surface oculaire ,
, Société Française d'ophtalmologie, rapport 2015 : Surface oculaire. Issy les Moulineaux, vol.2015, pp.159-163, 2018.
Dry eye disease: present challenges in the management and future trends, Curr Pharm Des, vol.22, pp.4470-90, 2016. ,
, The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Workshop, Ocul Surf, vol.5, pp.93-107, 2007.
A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada, Optom Vis Sci, vol.74, pp.624-655, 1997. ,
Prevalence of and risk factors for dry eye syndrome, Arch Ophthalmol, vol.118, pp.1264-1272, 2000. ,
Prevalence of dry eye syndrome among US women, Am J Ophthalmol, vol.136, pp.318-344, 2003. ,
, , 2008.
The epidemiology of dry eye in Melbourne, Australia. Ophthalmology, vol.105, pp.1114-1123, 1998. ,
Prevalence and risk factors associated with dry eye symptoms : a population based study in Indonesia ,
, Br J Ophthalmol, vol.86, pp.1347-51, 2002.
Prevalence of dry eye disease among Japanese visual display terminal users, Ophthalmology, vol.115, pp.1982-1990, 2008. ,
Prevalence and risk factors of dry eye isease in Japan : Koumi study, Ophthalmology, vol.118, pp.2361-2368, 2011. ,
,
, Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students, Am J Ophthalmol, vol.146, pp.925-934, 2008.
Prevalence of dry eye disease and its risk factors in visual display terminal users : the Osaka study, Am J Ophthalmol, vol.156, pp.759-66, 2013. ,
Dry eye in the Beaver Dam Offspring Study : prevalence, risk factors, and healthrelated quality of life, Am J Ophthalmol, vol.157, pp.799-806, 2014. ,
Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions, Arch Ophthalmol, vol.124, pp.1286-92, 2006. ,
Ocular surface changes in thyroid eye disease, Orbit, vol.32, pp.87-90, 2013. ,
Dry eye in diabetic patients, Am J Ophthalmol, vol.139, pp.498-503, 2005. ,
Review of external ocular disease associated with aids and HIV infection, Optom Vis Sci, vol.73, pp.225-255, 1996. ,
Ocular manifestations in patients with HTLV-I associated infection-a clinical study of 93 cases, Jpn J Ophthalmol, vol.40, pp.260-70, 1996. ,
Role of hyperosmolarity in the pathogenesis and management of dry eye disease : proceedings of the OCEAN group meeting, Ocul Surf, vol.4, pp.246-58, 2013. ,
Correlations in a change in aqueous tear evaporation with a change in relative humidity and the impact, Am J Ophthalmol, vol.141, pp.758-60, 2006. ,
Nutrient intake in women with primary and secondary Sjogren's syndrome, Eur J Clin Nutr, vol.57, pp.328-362, 2003. ,
Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women, Am J Clin Nutr, vol.82, pp.887-93, 2005. ,
Vitamin A deficiency and the global response, Forum Nutr, vol.56, pp.33-38, 2003. ,
Preservatives in eyedrops: the good, the bad and the ugly, Prog Retin Eye Res, vol.29, pp.312-346, 2010. ,
,
, Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the International Dry Eye WorkShop, Cochrane Database Syst Rev, vol.5, issue.8, pp.108-52, 2007.
Société Française d'ophtalmologie, rapport 2015 : Surface oculaire, vol.2015, pp.201-212 ,
Société Française d'ophtalmologie, rapport 2015 : Surface oculaire, vol.2015, pp.631-642 ,
Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye, Cornea, vol.26, pp.805-814, 2007. ,
A review of the complications of lacrimal occlusion with punctal and canalicular plugs, Orbit, vol.31, pp.86-93, 2012. ,
,
, Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study, Am J Ophthalmol, vol.138, pp.6-17, 2004.
Successful treatment of dry mouth and dry eye symptoms in Sjogren's syndrome patients with oral pilocarpine : a randomized, placebo-controlled, dose-adjustment study, J Clin Rheumatol, vol.10, pp.169-77, 2004. ,
Safety and efficacy of cyclosporine in the treatment of chronic dry eye, Ophthalmol Eye Dis, vol.6, pp.37-42, 2014. ,
Amniotic membrane transplantation in ocular surface disorders, Journal of the Indian Medical Association, vol.12, pp.726-735, 2004. ,
Greffes de membranes amniotiques : indications et techniques, Pisella PJ, Baudouin C, Hoang-Xuan T. Société Française d'ophtalmologie, rapport 2015 : Surface oculaire. Issy les Moulineaux, pp.561-570, 2015. ,
RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies, J Fr Ophtalmol, vol.36, pp.740-747, 2013. ,
PRGF eye drops stimulates scarless regeneration compared to autologous serum, Exp Eye Res, vol.135, pp.118-144, 2015. ,
,
, Autologous serum and plasma rich in growth factors in ophthalmology preclinical and clinical studies, Acta Ophthalmol, vol.93, pp.605-619, 2015.
Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months, Cornea, vol.32, pp.1380-1386, 2013. ,
,
Severe impairment of health-related quality of life in patients suffering from ocular surface diseases, J Fr Ophtalmol, vol.31, pp.369-78, 2008. ,
Impact of dry eye syndrome on vision-related quality of life, Am J Ophthalmol, vol.143, pp.409-424, 2007. ,
The relative burden of dry eye in patients' lives: comparisons to a US normative sample, Invest Ophthalmol Vis Sci, vol.46, pp.46-50, 2005. ,
UK patients with primary Sjogren's syndrome are at increased risk from clinical depression ,
, Gerodontology, vol.21, pp.141-146, 2004.
Autologous serum for ocular surface diseases ,
, Arq Bras Oftalmol, vol.71, issue.6, pp.47-54, 2008.
Traitements particuliers : Sérum autologue et thérapies matricielles ,
, Société Française d'ophtalmologie, rapport 2015 : Surface oculaire. Issy les Moulineaux, vol.2015, pp.571-584, 2018.
Time and temperature-dependent stability of growth factor peptides in human autologous serum eye drops, Cornea, vol.28, pp.200-205, 2009. ,
Neutrophic keratitis, Eye (Lond), vol.17, pp.989-95, 2003. ,
Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca, Arthritis Rheum, vol.27, pp.459-61, 1984. ,
Treatment of dry eye by autologous serum application in Sjogren's syndrome, Br J Ophthalmol, vol.83, pp.390-395, 1999. ,
Treatment of persistent corneal epithelial defect by autologous serum application, Ophthalmology, vol.106, pp.1984-1993, 1999. ,
Autologous serum tears: Long-term treatment in dry eye syndrome, J Fr Ophtalmol, vol.41, pp.246-254, 2018. ,
Autologous serum eye drops for the treatment of ocular surface disease, Eye Contact Lens, vol.41, pp.133-173, 2015. ,
Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome, Cornea, vol.33, pp.663-670, 2014. ,
GVHD dry eyes treated with autologous serum tears, Bone Marrow Transplant, vol.25, pp.1101-1104, 2000. ,
Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versushost disease, Cutan Ocul Toxicol, vol.36, pp.152-156, 2017. ,
,
, Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease, Cornea, vol.33, pp.1245-51, 2014.
Effectiveness of topical autologous serum treatment in neurotrophic keratopathy, Arch Soc Esp Oftalmol, vol.88, pp.302-308, 2013. ,
Use of autologous serum in the treatment of ocular surface disorders, Arch Ophthalmol, vol.129, pp.1610-1612, 2011. ,
Autologous serum 50 % eyedrops in the treatment of persistent corneal epithelial defects, Cornea, vol.28, pp.1104-1112, 2009. ,
, Ministère des solidarités et de la santé
, Règles de facturation des soins dispensés dans les établissements de santé (rétrocession des médicaments
Stability of Growth Factors in Autologous Serum Eyedrops After Long-Term Storage, Curr Eye Res, vol.41, pp.292-300, 2016. ,
Stability of serum eye drops after storage of 6 months, Cornea, vol.31, pp.1313-1321, 2012. ,
A protocol for microbiologically safe preparation, storage, and use of autologous serum eyedrops in low-income countries, J Infect Dev Ctries, vol.9, pp.55-64, 2015. ,